Enoxaparin Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Enoxaparin Sodium Injection (injection) from Sanofi-Aventis U.S. LLC with status To Be Discontinued. The shortage was first posted on Oct 20, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Sanofi-Aventis U.S. LLC
- Package NDC
- 0075-0626-03
- Dosage Form
- Injection
- Presentation
- Lovenox, Injection, 300 mg/3 mL (NDC 0075-0626-03)
- Initial Posting
- Oct 20, 2026